During a transformative phase in the healthcare industry, venture capitalists (VC) are gearing up for significant changes in trends and strategies in 2024. Despite a recent decline in M&A activity within digital health, a sense of optimism is growing, suggesting a potential resurgence in the coming year. Nathaniel Lacktman and Louis Lehot's article in mobihealthnews highlights several pivotal factors, including AI technologies, and a focus on remote patient monitoring (RPM), mental health, and patient-centric care models that will influence M&A strategies.
This article delves into the central role that remote patient monitoring (RPM) plays in shaping the decisions of healthcare M&A buyers.
Rise in demand for Remote Patient Monitoring (RPM)
A striking trend capturing the attention of M&A players is the surge in Remote Patient Monitoring (RPM). The expected proliferation of wearable devices and sensors facilitating continuous remote monitoring is set to be a key focus for healthcare M&A buyers. Beyond offering early detection of health issues, companies specializing in RPM are poised to be highly sought after, especially with Medicare expanding reimbursement for remote monitoring services.
Jiang Li, Ph.D., founder and CEO of Vivalink, also highlighted key remote patient monitoring trends for the United States in 2024 in MPO. These trends include:
Telehealth and monitoring integration
Telehealth and monitoring integration, once a basic service, has evolved to include continuous remote monitoring. The shift from occasional virtual interactions to real-time sensors providing a comprehensive 24/7 patient picture has gained momentum. Throughout 2024, the integration of telehealth, chronic, and acute patient monitoring into a unified digital healthcare platform is expected to continue.
Acceptance and adoption of Hospital-at-Home solutions
Hospital-at-Home (HaH) initiatives, allowing patients to receive hospital-level care at home, are gaining acceptance and adoption. Beyond financial considerations, the shift towards value-based care and governmental support is driving the adoption of at-home hospital care services. In 2024, reimbursements, value-based models, and government support are expected to further propel the global adoption of HaH solutions.
Wearable technology in Cardiology and Oncology
Cardiology and oncology are key areas where RPM will be increasingly implemented in 2024. Wearable technology, including cardiac patches, plays a vital role in addressing heart disease and monitoring post-treatment effects in cancer patients. Monitoring conditions like atrial fibrillation (AFib) and post-treatment symptoms remotely through wearable devices is crucial for managing health risks associated with cardiovascular disorders and post-treatment side effects.
Navigating regulatory changes for continued adoption
Key regulatory considerations will play a crucial role in 2024, particularly regarding the Acute Hospital Care at Home initiative. The initiative, extended through December 31, 2024, allows hospitals to provide inpatient care in the home. Additionally, the proposed Sustainable Cardiopulmonary Rehabilitation Services in the Home Act aims to permanently allow in-home cardiac and pulmonary rehabilitation services under Medicare. Navigating these regulatory intricacies will be vital for healthcare providers engaging with the evolving landscape of remote healthcare services.
As 2024 unfolds, the spotlight on RPM in healthcare M&A strategies underscores its pivotal role in shaping the future of healthcare delivery, with innovative solutions and patient-centric approaches at the forefront.